186 related articles for article (PubMed ID: 6148831)
1. Dantrolene--a new therapeutic approach to the neuroleptic malignant syndrome.
Bismuth C; de Rohan-Chabot P; Goulon M; Raphael JC
Acta Neurol Scand Suppl; 1984; 100():193-8. PubMed ID: 6148831
[TBL] [Abstract][Full Text] [Related]
2. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
Khan A; Jaffe JH; Nelson WH; Morrison B
J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
[TBL] [Abstract][Full Text] [Related]
3. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Ward A; Chaffman MO; Sorkin EM
Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F
Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201
[TBL] [Abstract][Full Text] [Related]
5. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
Schulte-Sasse U; Komar K; Eberlein HJ
Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
[TBL] [Abstract][Full Text] [Related]
6. The neuroleptic malignant syndrome--a review.
Gibb WR; Lees AJ
Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
[TBL] [Abstract][Full Text] [Related]
7. Current concepts. Neuroleptic malignant syndrome.
Guzé BH; Baxter LR
N Engl J Med; 1985 Jul; 313(3):163-6. PubMed ID: 3892294
[No Abstract] [Full Text] [Related]
8. Neuroleptic malignant syndrome.
Martin ML; Lucid EJ; Walker RW
Ann Emerg Med; 1985 Apr; 14(4):354-8. PubMed ID: 3985449
[TBL] [Abstract][Full Text] [Related]
9. Fatal thermal injury.
Denborough M
Med J Aust; 1989 May; 150(10):608. PubMed ID: 2716576
[No Abstract] [Full Text] [Related]
10. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
[No Abstract] [Full Text] [Related]
11. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
Kouparanis A; Bozikas A; Spilioti M; Tziomalos K
Brain Inj; 2015; 29(5):658-60. PubMed ID: 25625410
[TBL] [Abstract][Full Text] [Related]
13. [Dantrolene. Pharmacological and therapeutic aspects].
Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
15. [Pathophysiology and therapy of malignant neuroleptic syndrome].
Weller M; Kornhuber J
Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome following cardiac surgery: successful treatment with dantrolene.
Mieno S; Asada K; Horimoto H; Sasaki S
Eur J Cardiothorac Surg; 2003 Sep; 24(3):458-60. PubMed ID: 12965323
[TBL] [Abstract][Full Text] [Related]
17. [Protracted recurrent neuroleptic malignant syndrome].
Delerue O; Destée A
Rev Neurol (Paris); 1990; 146(8-9):515-7. PubMed ID: 2237099
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment of the neuroleptic malignant syndrome using i.v. dantrolene sodium in the neurologic intensive care station].
Rechlin T; Hilz MJ; Claus D
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 May; 26(3):156-60. PubMed ID: 1873425
[TBL] [Abstract][Full Text] [Related]
19. Mortality from neuroleptic malignant syndrome.
Shalev A; Hermesh H; Munitz H
J Clin Psychiatry; 1989 Jan; 50(1):18-25. PubMed ID: 2562951
[TBL] [Abstract][Full Text] [Related]
20. Therapy of neuroleptic malignant syndrome.
Lazarus A
Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
